From the perspective of fatty acid metabolism, we integrated multiple datasets to explore the role of ALDH2 in the prognosis of PCa and provide insights into the tumor immune microenvironment (TME) for those patients undergoing radical radiotherapy, which might enlighten the effect of ALDH2 on tumor stemness and multidrug resistance in the future. The gene discussed is ALDH2; the disease is neoplasm.